Zimmer Biomet launches new foot and ankle system
January 22, 2026
Zimmer Biomet (NYSE: ZBH)+
recently announced the Brachiator mini-rail external fixation system.
Zimmer Biomet (NYSE: ZBH)+
recently announced the Brachiator mini-rail external fixation system.
The project began at the University of Pittsburgh’s Makerspace during the Pitt Challenge Healthcare Hackathon in 2021 and has since grown into a community driven effort.
Johnson & Johnson (NYSE: JNJ)+
announced that it launched the Arbrea Breast Simulator Surgeon App for Mentor in the U.S.
Sequel Med Tech and Diabeloop today announced a collaboration to integrate a new algorithm into the twiist automated insulin pump.
Medtronic this week launched its OmniaSecure defibrillation lead in the U.S., describing it as the world’s smallest.
Peezy Midstream is available to Primary Care Providers, showing excellent clinical evidence around reduced false-positives and reduced specimen contamination evidenced by a Public Health Wales GP study, showing a 66% saving on lab spend.
The B3 GEL System maintains biomechanical separation throughout the essential healing window.
The company will use the money to try to establish its cuffless device as a go-to option for 24-hour blood pressure monitoring in the U.S.
Picard Medical, the company behind the SynCardia Total Artificial Heart (TAH), announced today that it plans to launch a new, FDA-cleared artificial heart accessory.
ABBOTT PARK, Ill., Jan. 5, 2026 /PRNewswire/ — Abbott (NYSE: ABT), a leading healthcare company, today unveiled Libre Assist,1 a groundbreaking feature within the Libre app5 designed to help the millions of people living with diabetes in the U.S. better understand how the foods they eat affect their glucose levels. 1,2 Unlike traditional food logging apps that only give feedback after a meal is logged, Libre Assist1 helps people make informed mealtime decisions before they eat. Abbott is launching the new technology during CES 2026 in Las Vegas.